Home>Video>2 Funds for Tapping Into GMO's Worldview

2 Funds for Tapping Into GMO's Worldview

Thu, 2 Jul 2015

Although both funds represent GMO's asset-allocation views well and earn Silver ratings, GMO Benchmark-Free is a pure play on the firm's views, while GMO Global Asset Allocation is more benchmark-conscious.

+

Video Transcript

Leo Acheson: Both GMO Benchmark-Free (GBMFX) and GMO Global Asset Allocation (GMWAX) are managed by GMO's asset-allocation team, which is led by Ben Inker. The team is well known for its bold seven-year asset-class forecast, which they derive from their outlooks for current market valuations and profit margins as well as the belief that they will inevitably revert to their long-run averages.

Both funds invest across the globe in equities, fixed income, and alternatives. Once GMO makes its forecasts, it sticks with those views. Their patience, over time, has paid off.

In terms of differences, GMO Benchmark-Free has fewer constraints and is more of a pure play on GMOs asset-class views. The managers aim to earn 5% return above inflation while keeping standard deviation within 5% to 10%. That's about the only constraint the fund has. Meanwhile, GMO Global Asset Allocation implements the team's asset-allocation views in more of a benchmark-conscious way.

The strategy aims to beat a blended benchmark of 65% MSCI All Country World Index and 35% Barclays U.S. Aggregate Bond Index by at least two percentage points annualized, with 3% to 5% tracking error. As a result, the portfolio is not as pure of a representation of GMO's views. So, for instance, GMO currently has a bleak outlook for expected returns from equities.

As a result, at the end of the first quarter of 2015, GMO Benchmark-Free held just 40% of assets in equities, which is at the low end of its typical range, while GMO Global Asset Allocation held 52% in stocks. The difference is that GMO felt compelled to hold a higher equity allocation in Global Asset Allocation to ensure that tracking error relative to the benchmark stays within the targeted range.

Overall, both funds are a solid option and draw upon a well-resourced and proven team at GMO; however, investors who want exposure to GMO's highest-conviction portfolio should stick with GMO Benchmark-Free.

For retail investors looking to access these strategies, Wells Fargo offers Wells Fargo Advantage Absolute Return (WARAX), which earns a Bronze rating, and Wells Fargo Advantage Asset Allocation (EAAFX), which earns a Neutral rating.

  1. Related Videos
  2. Related Articles
  1. 3 Potential Red Flags in Your 529 Plan

    College savers should make sure their 529 program manager has a sensible asset allocation , reasonable fees, and is choosing from the best strategies available to them, says Morningstar's Leo Acheson.

  2. A 5-Point Portfolio Risk Checkup for Investors

    Audit your investments for overexposure to riskier equities, geographies, and interest-rate sensitive fare with these tips from Morningstar's Christine Benz.

  3. Christine Benz's Midyear Portfolio Checkup

    Christine recaps the market's activity for the first half of 2015 and provides a checklist for investors to use to evaluate their portfolios midyear.

  4. Midyear Portfolio Checkup: 4 Retiree To-Dos

    Make sure you have enough liquid reserves, check the big-picture asset allocation , take stock of your withdrawals, and evaluate your portfolio's interest-rate sensitivity, says Morningstar's Christine Benz.

  5. How to Make the Most of Your 401(k)

    In this special presentation, get the answers to key questions about the quality of your plan, whether your savings are on track with your goals, how to allocate assets, and what to do with assets when you leave your job.

  6. 3 Reasons Your Asset Allocation May Not Be What It Appears

    Tax effects, maneuvers by your active fund managers, and the global sales of multinational companies can impact your actual portfolio exposures.

  7. Kinniry: A Double Hurdle for Tactical Asset Allocation

    Not only are the probabilities stacked against tactical allocation strategies, but even the successful ones can be hard for investors to stick with, says Vanguard senior investment strategist Fran Kinniry.

  8. Fund Favorites and Follies Over 20 Years

    In this special 50-minute panel discussion, Morningstar's Christine Benz, Russ Kinnel, and John Rekenthaler chart fund investing's course over the last two decades, discuss investors' biggest challenges today, and reveal some of their favorite longtime picks.

©2017 Morningstar Advisor. All right reserved.